Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Sprynski, Anne Catherine [VerfasserIn]   i
 Hose, Dirk [VerfasserIn]   i
 Caillot, Laurent [VerfasserIn]   i
 Réme, Thierry [VerfasserIn]   i
 Shaughnessy, John D., Jr [VerfasserIn]   i
 Barlogie, Bart [VerfasserIn]   i
 Seckinger, Anja [VerfasserIn]   i
 Moreaux, Jérôme [VerfasserIn]   i
 Hundemer, Michael [VerfasserIn]   i
 Jourdan, Michel [VerfasserIn]   i
 Meißner, Tobias [VerfasserIn]   i
 Jauch, Anna [VerfasserIn]   i
 Mahtouk, Karène [VerfasserIn]   i
 Kassambara, Alboukadel [VerfasserIn]   i
 Bertsch, Uta [VerfasserIn]   i
 Rossi, Jean François [VerfasserIn]   i
 Goldschmidt, Hartmut [VerfasserIn]   i
 Klein, Bernard [VerfasserIn]   i
Titel:The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor
Verf.angabe:Anne Catherine Sprynski, Dirk Hose, Laurent Caillot, Thierry Réme, John D., Jr Shaughnessy, Bart Barlogie, Anja Seckinger, Jérôme Moreaux, Michael Hundemer, Michel Jourdan, Tobias Meißner, Anna Jauch, Karène Mahtouk, Alboukadel Kassambara, Uta Bertsch, Jean François Rossi, Hartmut Goldschmidt, and Bernard Klein
E-Jahr:2009
Jahr:[May 7 2009]
Umfang:13 S.
Illustrationen:Illustrationen
Fussnoten:Prepublished online as Blood first edition paper, February 24, 2009 ; Gesehen am 14.01.2022
Titel Quelle:Enthalten in: Blood
Ort Quelle:Washington, DC : American Society of Hematology, 1946
Jahr Quelle:2009
Band/Heft Quelle:113(2009), 19, Seite 4614-4626
ISSN Quelle:1528-0020
Abstract:A plethora of myeloma growth factors (MGFs) has been identified, but their relative importance and cooperation have not been determined. We investigated 5 MGFs (interleukin-6 [IL-6], insulin-like growth factor type 1 [IGF-1], hepatocyte growth factor [HGF], HB-epidermal growth factor [HB-EGF], and a proliferation-inducing ligand [APRIL]) in serum-free cultures of human myeloma cell lines (HMCLs). In CD45− HMCLs, an autocrine IGF-1 loop promoted autonomous survival whereas CD45+ HMCLs could not survive without addition of MGFs, mainly IGF-1 and IL-6. IGF-1 was the major one: its activity was abrogated by an IGF-1R inhibitor only, whereas IL-6, HGF, or HB-EGF activity was inhibited by both IGF-1R- and receptor-specific inhibition. APRIL activity was inhibited by its specific inhibitor only. Of the investigated MGFs and their receptors, only expressions of IGF-1R and IL-6R in multiple myeloma cells (MMCs) of patients delineate a group with adverse prognosis. This is mainly explained by a strong association of IGF-1R and IL-6R expression and t(4;14) translocation, but IGF-1R expression without t(4;14) can also have a poor prognosis. Thus, IGF-1-targeted therapy, eventually in combination with anti-IL-6 therapy, could be promising in a subset of patients with MMCs expressing IGF-1R.
DOI:doi:10.1182/blood-2008-07-170464
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1182/blood-2008-07-170464
 DOI: https://doi.org/10.1182/blood-2008-07-170464
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1786047667
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68866488   QR-Code
zum Seitenanfang